Search the Site


test tubes

Five Near-Term, Low-Priced Bio-Catalyst Stock Trades

publication date: Jun 12, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Written by Mike Havrilla--Below are a summary of five bio-pharmaceutical stocks trading around $10 or less with FDA decisions or late-stage Phase 3 clinical trial catalysts expected over the next few weeks to months. 

Sorry this page is available to subscribers only. 

You can also sign up for our 100% FREE Newsletter  to stay current on public webinars, special offers, and news alerts:


If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.